Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The islet amyloid polypeptide receptor, also known as the amylin receptor, is a G protein-coupled receptor complex that mediates the physiological and pathological effects of islet amyloid polypeptide (IAPP), also known as amylin. It consists of a calcitonin receptor (CTR) core protein complexed with one of several possible Receptor Activity-Modifying Proteins (RAMPs). The amylin receptor plays key roles in metabolic regulation and has been implicated in both type 2 diabetes mellitus (T2DM) and neurodegenerative diseases such as Alzheimer’s disease.
Amylinomimetic drugs like pramlintide act on these receptors to regulate glucose homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Islet Amyloid Polypeptide Receptor (Amylin Receptor).